The Effect of Propofol on Dexamethasone-induced Perineal Pruritus
1 other identifier
interventional
40
1 country
1
Brief Summary
patients may appear serious perineal itching, after injection of dexamethasone sodium phosphate injection its incidence is about 25% \~ 100%, and the incidence of the discomfort in females was much higher than that of the maleTo investigate the effect of propofol pretreatment on perineal pruritus induced by dexamethasone sodium phosphate injection and explore the possible machanisms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for early_phase_1
Started Sep 2020
Shorter than P25 for early_phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 3, 2020
CompletedFirst Posted
Study publicly available on registry
April 7, 2020
CompletedStudy Start
First participant enrolled
September 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2020
CompletedFebruary 25, 2022
February 1, 2022
1 month
April 3, 2020
February 8, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
visual analogue scale(VAS) scores
VAS score was used to grade the degree of perineal itching: VAS 0 was no discomfort, 1-3 was mild, 4-6 was moderate, and 7-10 was severe
in 3min
Secondary Outcomes (1)
the occurrence of adverse reactions
in 3min
Study Arms (2)
normal saline (N) group
PLACEBO COMPARATORBefore anesthesia induction, N group received corresponding intravenous normal saline of the same volume.
propofol (P) group
ACTIVE COMPARATORBefore anesthesia induction, P group received intravenous injection of 0.3mg/kg propofol
Interventions
Before anesthesia induction, M group received intravenous injection of 0.3mg/kg Propofol, while N group received corresponding intravenous normal saline of the same volume. After 1 min, both groups received intravenous injection of dexamethasone sodium phosphate injection of 10mg.
Before anesthesia induction, M group received intravenous injection of 0.3mg/kg Propofol, while N group received corresponding intravenous normal saline of the same volume. After 1 min, both groups received intravenous injection of dexamethasone sodium phosphate injection of 10mg.
Eligibility Criteria
You may qualify if:
- Elective female surgery patients, ages 18 to 65 years old, ASA Ⅰ or Ⅱ level, body mass index (BMI) of 18 \~ 30 kg/m2.
You may not qualify if:
- diabetes mellitus, paresthesia, allergy to narcotic drugs, routine preoperative use of narcotic analgesics, long-term use of hormones, drug and alcohol abuse, communication disorders in psychiatric disorders, pregnancy or lactation, and patients with severe systemic diseases and unwilling to undergo the trial.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Affiliated hospital of yangzhou university
Yangzhou, Jiangsu, 225100, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- early phase 1
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Affiliated hospital of Yangzhou university
Study Record Dates
First Submitted
April 3, 2020
First Posted
April 7, 2020
Study Start
September 1, 2020
Primary Completion
October 1, 2020
Study Completion
November 30, 2020
Last Updated
February 25, 2022
Record last verified: 2022-02
Data Sharing
- IPD Sharing
- Will not share